RARA and neoplasm: RARα deficiency led to the increased CAR‐T cell performance in a manner similar to the effect of overexpressed BATF or decreased expression of other transcription factors such as NR4A.[4, 26] We did not find significant differences in the tumor‐killing activities between WT and RARα‐TG CAR T cells.